US Patent Issued to Boehringer Ingelheim International on Jan. 20 for "Multi-specific binding proteins for cancer treatment" (American, Austrian Inventors)

ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,528,879, issued on Jan. 20, was assigned to Boehringer Ingelheim International GmbH (Ingelheim am Rhein, Germany).

"Multi-specific binding proteins for cancer treatment" was invented by Susanne Hipp (Vienna), Paul Adam (Vienna), Michael Dziegelewski (Newburgh, N.Y.), Rajkumar Ganesan (Blue Bell, Pa.), Philip Nicholas Gorman (Prospect, Conn.), Pankaj Gupta (Scarsdale, N.Y.), Priyanka Gupta (Danbury, Conn.), Justin Scheer (Ridgefield, Conn.) and Vladimir H. Voynov (Danbury, Conn.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to novel DLL3/CD3 binding proteins. The invention also relates to nucleic acids encoding such protein...